ASTERA LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.51 USD | +0.01% |
|
+3.20% | 0.00% |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 11,288 | - | - |
| Enterprise Value (EV) 1 | 10,574 | 10,440 | 10,293 |
| P/E ratio | -85.4 x | -299 x | 966 x |
| Yield | - | - | - |
| Capitalization / Revenue | 37.1 x | 26.1 x | 18.5 x |
| EV / Revenue | 34.8 x | 24.1 x | 16.8 x |
| EV / EBITDA | 138 x | 1,710 x | 122 x |
| EV / FCF | 492 x | 169 x | 77.3 x |
| FCF Yield | 0.2% | 0.59% | 1.29% |
| Price to Book | 13.9 x | 13.2 x | 11.5 x |
| Nbr of stocks (in thousands) | 155,701 | - | - |
| Reference price 2 | 72.50 | 72.50 | 72.50 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 304 | 432.4 | 611.3 |
| EBITDA 1 | - | 76.41 | 6.104 | 84.5 |
| EBIT 1 | - | 70.57 | 116.7 | 201 |
| Operating Margin | - | 23.21% | 26.99% | 32.87% |
| Earnings before Tax (EBT) 1 | - | -111.1 | -1.9 | - |
| Net income 1 | -26.26 | -146.4 | -46.33 | 11.2 |
| Net margin | - | -48.15% | -10.72% | 1.83% |
| EPS 2 | -0.7100 | -0.8488 | -0.2427 | 0.0750 |
| Free Cash Flow 1 | - | 21.5 | 61.65 | 133.2 |
| FCF margin | - | 7.07% | 14.26% | 21.79% |
| FCF Conversion (EBITDA) | - | 28.14% | 1,009.91% | 157.64% |
| FCF Conversion (Net income) | - | - | - | 1,189.76% |
| Dividend per Share 2 | - | - | - | - |
| Announcement Date | 24-02-21 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|
| Net sales 1 | 65.26 | 72.53 | 79.44 | 86.44 | 91.3 | 99.54 |
| EBITDA 1 | 16.49 | 17.07 | 19.49 | 23.04 | 25.4 | 24.1 |
| EBIT 1 | 15.87 | 15.94 | 18.03 | 21.01 | 22.08 | 25.1 |
| Operating Margin | 24.32% | 21.98% | 22.7% | 24.3% | 24.18% | 25.22% |
| Earnings before Tax (EBT) 1 | -80.41 | -14.2 | -10 | -6.5 | -6.3 | -1.7 |
| Net income 1 | -93 | -19.47 | -18.57 | -16.82 | -14.81 | -12.86 |
| Net margin | -142.5% | -26.84% | -23.38% | -19.46% | -16.22% | -12.92% |
| EPS 2 | -1.770 | -0.1164 | -0.1109 | -0.0999 | -0.0788 | -0.0695 |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 24-05-08 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 714 | 849 | 995 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | 21.5 | 61.7 | 133 |
| ROE (net income / shareholders' equity) | - | 20.2% | 3.58% | 8.96% |
| ROA (Net income/ Total Assets) | - | 13.7% | 11.2% | 15.4% |
| Assets 1 | - | -1,069 | -415.4 | 72.78 |
| Book Value Per Share 2 | - | 5.200 | 5.510 | 6.290 |
| Cash Flow per Share 2 | - | 0.2700 | 0.7200 | 1.050 |
| Capex 1 | - | 29.4 | 52.5 | 47 |
| Capex / Sales | - | 9.67% | 12.14% | 7.69% |
| Announcement Date | 24-02-21 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
72.5
USD
Average target price
87.73
USD
Spread / Average Target
+21.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 11.29B | |
| +91.39% | 2,275B | |
| +40.81% | 673B | |
| +26.68% | 647B | |
| +12.83% | 266B | |
| +36.74% | 216B | |
| +16.86% | 178B | |
| +51.16% | 139B | |
| -36.12% | 135B | |
| +47.00% | 115B |
- Stock Market
- Equities
- ALAB Stock
- Financials Astera Labs, Inc.
